18F-FMAU PET for Prostate Cancer Diagnosis

Phase 1, open-label, single-arm trial, sponsored by University of Southern California. Primary endpoints: Proportion of men for whom biopsy cores taken based only on the 18F-FMAU PET/CT results would have yielded the same overall diagnosis as the standard TRUS-guided core or the mpMRI-directed prostate… up to 1 year, Proportion of men for whom the 18F-FMAU PET/CT identified all lesions that were found to have cancer based on the standard TRUS-guided and the mpMRI directed core prostate biopsies up to 1 year and 1 more. Started Sep 2016; status: terminated.